Fusion Online Logo

Science at a click

An international, virtual community at your fingertips.

In May 2021, we officially launch Fusion Online, our virtual conference platform. Following the impacts of the pandemic, we realised there was a long term need for both virtual and live meetings. Which lead us to developing our very own virtual conference platform, tailored to the specific needs of academic meetings which we can continue to shape and improve as our virtual meetings evolve.

Not only is Fusion Online more accessible, more convenient and more affordable, but the platform offers a friendly and welcoming environment for fellow researchers to come together to share unpublished data, challenge theories, discuss controversial subjects and above all, create flourishing collaborations. We are excited about the possibilities and opportunities virtual meetings offer as well as the additional perks such as: the reduced carbon footprints, no visas required, no travel restrictions or travel related costs and more affordable registration fees.

A taster of our virtual conference calendar can be found below. Registration will open from 01st May 2021, but in the meantime, you can sign up to receive updates.

We look forward to welcoming you to our virtual community, The Fusion Family

Date: 26th to 28th July, 2021 Time Zone: London, UK

2nd Targeting Therapy of Alzheimer’s and Related Neurodegenerative Diseases Virtual Conference

Neurodegenerative diseases such as Alzheimer’s, Parkinson’s, FTS and ALS affect over 5 million people in the US and over 35 million people worldwide. Alzheimer’s disease (AD) is the most common age-dependent neurodegenerative disease and currently, only four drugs are approved for alleviating symptoms in AD patients, with no new therapies approved by FDA since 2003. Other related neurodegenerative diseases such as Parkinson’s disease (PD), Huntington’s disease (HD), and amyotrophic lateral sclerosis (ALS) are also age-dependent and lack effective therapies. Hence, finding cures for AD and other related neurodegenerative diseases is urgent and various approaches should be actively pursued. This planned conference intends to bring leading scientists and clinicians from all over the world to present their unpublished observations or findings to attendees and to share their vision or prospects on translational research. The talks and poster presentations will include the most updated therapeutic strategies, newly discovered therapeutic targets, and recent clinical developments at various stages in the area of Alzheimer’s and related neurodegenerative diseases.

Key Topics

  • BACE1 inhibitors and/or γ-secretase modulators for reducing amyloid deposition
  • Active and passive vaccination for enhancing clearance of amyloid plaques
  • Vaccines for reducing tau pathology
  • Antisense approaches for AD, PD and ALS therapy
  • Neural stem cell approaches for neurodegeneration
  • Inflammatory modulators for neurodegeneration
  • Genetic linkage study and big data approaches
  • Novel therapeutic targets


Peter St George-Hyslop (The Tanz Centre for Research in Neurodegenerative Diseases), Li-Huei Tsai (MIT) and Riqiang Yan (University of Connecticut Health Center).

Confirmed Invited Speakers

Ed Boyden (MIT), Christine Van Broeckhoven (University of Antwerp), Li Gan (Weill Cornell Medical College), Dave Holtzman (Washington University), Yadong Huang (Gladstone Institutes), Nancy Ip (The Hong Kong University of Science and Technology), Manolis Kellis (MIT), Jonathan Kipnis (Washington University School of Medicine in St. Louis), Ken Kosik (UC Santa Barbara), Yueming Li (Memorial Sloan Kettering Cancer Center), Shane Liddelow (NYU Langone Health), Andreas Pfenning (Carnegie Mellon University), Domenico Pratico (Temple University), Anne Schaefer (Icahn School of Medicine at Mount Sinai), Annabelle Singer (Emory University), Sam Sisodia (University of Chicago) and Bob Vasser (Northwestern University).


Registration Opens: 01 May 2021

Talk Submission: 25 June 2021

Poster Submission: 05 July 2021

Registration Closes: 19 July 2021

Please send oral and poster abstract submissions via email to the Conference Manager, Emily.

Sign up for updates Registration Deadline
19th July 2021

Date: 1st to 3rd September, 2021 Time Zone: London, UK

Epithelial Stem Cell - Niche Interactions in Lung Development, Homeostasis, Regeneration and Disease Virtual Conference

In the last years, a significant advance in the field of respiratory stem cell biology has occurred. It has been acquired deeper knowledge about the identity, regulation and functions of lung epithelial stem cells during development, homeostasis, regeneration and disease. Even novel lung epithelial progenitor cells that develop after injury and that are necessary intermediates during regeneration have been identified.

Lung stem cell niches including supportive stromal cells as well as the extracellular matrix (compounds and biomechanics) where they are embedded in, are currently better defined. However, there is still little knowledge about the regulation of lung stem cell behaviour by the niche and further investigation is required. Understanding the interactions between lung stem cells and their niche as well as studying how changes in the local microenvironment affect stem cell behaviour, will contribute to comprehend the development of disease and to discover novel therapeutic approaches.

Key Topics

  • Airway and Alveolar Stem cells in lung health and disease
  • Novel epithelial progenitor cell populations
  • Epithelial-mesenchymal interactions in lung development, regeneration and disease
  • Embryonic lung stem cell niche in lung development
  • Stem cell niches in lung homeostasis and repair
  • Mechanical regulation of lung stem cells


Ana Pardo-Saganta (CIMA - University of Navarra) and Saverio Bellusci (Justus-Liebig-Universitaet Giessen, ECCPS).


Registration Opens: 01 May 2021

Talk Submission: 30 June 2021

Poster Submission: 11 August 2021

Registration Closes: 11 August 2021

Please send oral and poster abstract submissions via email to the Conference Manager, Jack.

Sign up for updates Registration Deadline
7th July 2021

Date: 19th to 21st October, 2021 Time Zone: London, UK

4th Interventions in Aging Virtual Conference

A plethora of genetic, dietary and pharmacological interventions can extend healthy lifespan in laboratory animals, and can delay or ameliorate diverse aging-related diseases. Mechanisms of aging are conserved in evolution, and discoveries made in animals are informing our understanding of human aging. This raises the intriguing possibility of performing preventative medicine against chronic and age-related diseases, by targeting their main risk factor, namely aging. Important current challenges in the field are (1) to understand the downstream pathways by which longevity interventions can combat age-related loss of function and pathology, (2) to evaluate the impact of regenerative interventions and cellular reprogramming on age-related diseases, and (3) to translate the findings into the extension of human health span. 

This fourth meeting will continue to explore these topics, with particular emphasis on what we can learn from variation in the rate of ageing in the natural world, mitochondria, cellular senescence, biomarkers and epidemiology, immune aging and reprogramming and rejuvenation strategies.

Key Topics

  • Mitochondrial quality control and aging
  • Autophagy and proteostasis
  • Regenerative interventions and cellular reprogramming
  • Human ageing: biomarkers and cell senescence


Heinrich Jasper (Genentech) and Linda Partridge (University College London).

Confirmed Keynote Speakers

Yves Barral (ETH Zurich), Ivan Dikic (Goethe University), Nils Goran Larsson (Karolinska Institutet) and Joan Mannick (resTORbio).

Confirmed Invited Speakers

Joris Deelen (Max Planck Institute for Biology of Ageing, Cologne), Robin Franklin (University of Cambridge), Judith Frydman (Stanford University), Martin Graef (Max Planck Institute for Biology of Ageing, Cologne), Cole Haynes (University of Massachusetts), Brian Kennedy (National University of Singapore), Joana Neves (University of Lisbon), Tom Reh (University of Washington), John Sedivy (Brown University), Pedro Sousa Victor (University of Lisbon), Thaddeus Stappenbeck (Cleveland Clinic Lerner Research Institute) and Claire J. Steves (Kings College London).


Registration Opens: 01 May 2021

Talk Submission: 10 August 2021

Poster Submission: 18 September 2021

Registration Closes: 12 October 2021

Please send oral and poster abstract submissions via email to the Conference Manager, Chloe.

Sign up for updates Registration Deadline
12th October 2021

Date: TBA (coming spring 2022)

3rd Neuroepigenetics & Neuroepitranscriptomics Virtual Conference

Epigenetic mechanisms - including DNA and histone modifications, as well as regulation by non-coding RNAs - have pivotal roles in the nervous system. Aberrant epigenetic regulation also contributes to pathogenesis in various brain disorders. There are a number of recent ground-breaking discoveries of new features of epigenetic marks and regulation that are enriched in the nervous system, leading to an emerging new field of “neuroepigenetics”. In addition, new discoveries of modification of mRNAs and long non-coding RNAs lead to a new field of “epitranscriptomics”. The second meeting in the series will bring together experts and pioneers in studying neuroepigenetics and epitranscriptomics to provide an up-to-date and comprehensive picture of epigenetic and epitranscriptomic mechanisms in neural development, reprogramming and cell identity, plasticity, neuronal function and dysfunction. The meeting will offer opportunity for interdisciplinary interactions and future collaborations.


Hongjun Song (University of Pennsylvania) and Li-Huei Tsai (MIT).

Further details available soon.

Sign up for updates Registration Deadline